NCT00377793View on ClinicalTrials.gov

Levitra (Vardenafil, BAY38-9456) Partner Satisfaction Study II

PHASE4CompletedINTERVENTIONAL
Enrollment

352

Participants

Timeline

Start Date

July 31, 2006

Study Completion Date

August 31, 2007

Conditions
Sexual DysfunctionMale Erectile Dysfunction
Interventions
DRUG

Levitra (Vardenafil, BAY38-9456)

DRUG

Placebo

Trial Locations (47)

1000

Bruxelles - Brussel

2090

Johannesburg

2940

Newcastle

3000

Leuven

3600

Genk

4000

Liège

4037

Durban

4091

Durban

8800

Roeselare

9324

Bloemfontein

13009

Marseille

13275

Marseille

17000

La Rochelle

20132

Milan

20251

Hamburg

20354

Hamburg

22177

Hamburg

23812

Wahlstedt

24128

Bergamo

30625

Hanover

31000

Toulouse

36211

Vigo

38320

San Cristóbal de La Laguna

40000

Mont-de-Marsan

42103

Wuppertal

45468

Mülheim

46010

Valencia

50139

Florence

50321

Brühl

59000

Lille

69000

Lyon

75009

Paris

80131

Napoli

02625

Bautzen

01129

Dresden

04105

Leipzig

04703

Leisnig

01662

Meißen

00155

Roma

6836 BH

Arnhem

7415 EH

Deventer

7511 JX

Enschede

7442 LS

Nijverdal

03010

Alicante

08034

Barcelona

08430

La Roca del Vallès

08025

Barcelona

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT00377793 - Levitra (Vardenafil, BAY38-9456) Partner Satisfaction Study II | Biotech Hunter | Biotech Hunter